About
Gut Bacteria Phenotype to Biomarker/Therapeutics
Areas of Focus
Categories
Microbiome
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
1,870
By Phase
PHASE1: 2
By Status
ACTIVE_NOT_RECRUITING: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06582264Lead Sponsor
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
PHASE1Active, not recruiting
29 participants
Started: Sep 27, 2024 · Completed: Jan 31, 2026
NCT06540391Lead Sponsor
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
PHASE1Active, not recruiting
41 participants
Started: Aug 28, 2024 · Completed: Aug 31, 2027
NCT04107168Collaborator
Microbiome Immunotherapy Toxicity and Response Evaluation
N/AUnknown
1,800 participants
Started: Jul 8, 2020 · Completed: Jul 8, 2025
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...